卵巢癌确诊时加速遗传咨询转诊路径: uptake与心理影响
本研究纳入100例新诊断卵巢癌患者,由妇科肿瘤医生转诊并经遗传导航员联系安排遗传咨询。患者报告的压力和焦虑在检测时存在但6个月时改善。公立医院患者接受遗传咨询的比例低于私立医院(56% vs 84%,P=0.021)。
要点
- 检测者中16%携带致病性胚系突变,以BRCA1/2为主。
- 心理困扰短期存在但6个月改善,不应阻碍早期转诊。
核心结论
- 卵巢癌确诊时通过遗传导航员加速转诊可有效提高遗传咨询和检测接受率,且不造成长期心理负担。
研究设计与样本
- 前瞻性队列研究,2015至2018年纳入100例新诊断卵巢癌患者,由妇科肿瘤医生转诊并经遗传导航员联系安排遗传咨询。
主要发现
- 从确诊到遗传咨询的中位时间为34天(范围10-189天)。
- 检测者中12例(16%)携带致病性胚系突变:BRCA1 7例、BRCA2 4例、MSH2 1例。
- 公立医院患者接受遗传咨询的比例低于私立医院患者(56% vs 84%,P=0.021)。
临床怎么用
- 临床应在新诊断卵巢癌时尽早通过遗传导航员加速转诊至遗传咨询,不必因担心心理困扰而延迟。
- 对公立医院患者需关注转诊障碍,采取额外措施提高遗传咨询接受率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Timely genetic testing at ovarian cancer diagnosis is essential as results impact front line treatment decisions. Our objective was to determine rates of genetic counseling and testing with an expedited genetics referral pathway wherein women with newly-diagnosed ovarian cancer are contacted by a genetics navigator to facilitate genetic counseling. METHODS: Patients were referred for genetic counseling by their gynecologic oncologist, contacted by a genetics navigator and offered appointments for genetic counseling. Patients completed quality of life (QoL) surveys immediately pre- and post-genetic assessment and 6 months later. The primary outcome was feasibility of this pathway defined by presentation for genetic counseling. RESULTS: From 2015 to 2018, 100 patients were enrolled. Seventy-eight had genetic counseling and 73 testing. Median time from diagnosis to genetic counseling was 34 days (range 10-189). Among patients who underwent testing, 12 (16%) had pathogenic germline mutations (BRCA1-7, BRCA2-4, MSH2-1). Sixty-five patients completed QoL assessments demonstrating stress and anxiety at time of testing, however, scores improved at 6 months. Despite the pathway leveling financial and logistical barriers, patients receiving care at a public hospital were less likely to present for genetic counseling compared to private hospital patients (56% versus 84%, P = 0.021). CONCLUSIONS: Facilitated referral to genetic counselors at time of ovarian cancer diagnosis is effective, resulting in high uptake of genetic counseling and testing, and does not demonstrate a long term psychologic toll. Concern about causing additional emotional distress should not deter clinicians from early genetics referral as genetic testing can yield important prognostic and therapeutic information.
引用
- Frey MK, Lee SS, Gerber D, et al. Facilitated referral pathway for genetic testing at the time of ovarian cancer diagnosis: uptake of genetic counseling and testing and impact on patient-reported stress, anxiety and depression. Gynecol Oncol. 2020. PMID: 32057464. doi:10.1016/j.ygyno.2020.01.007
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。